Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population
Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population have?
Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population has 37 citations in the OpenAlex counts ScholarIQ stores.
When was Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population published?
Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population has 2015 year in the ScholarIQ index.
What is the open-access status of Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population?
Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population has bronze oa status in the ScholarIQ index.
What is the DOI of Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population?
The DOI for Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population is on the source record.
What is the PMID of Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population?
The PMID for Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population is on the source record.
What is the OpenAlex record for Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population?
The OpenAlex for Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population is on the source record.